Immunome Inc. (IMNM) Social Stream
IMMUNOME INC (IMNM) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering IMMUNOME INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-29 | 2 | $35.001 | $21 | $28 | $11.12 | 151.8% |
| 2021-11-16 | 2 | $35 | $21 | $28 | $11.12 | 151.8% |
| 2022-01-11 | 2 | $33 | $21 | $27 | $11.12 | 142.81% |
| 2022-03-30 | 2 | $16 | $16 | $16 | $11.12 | 43.88% |
| 2022-04-01 | 2 | $33 | $16 | $24.5 | $11.12 | 120.32% |
| 2022-04-25 | 2 | $16 | $14 | $15 | $11.12 | 34.89% |
| 2022-05-09 | 2 | $16 | $14.001 | $15 | $11.12 | 34.89% |
| 2022-08-08 | 2 | $14.001 | $9 | $11.5 | $11.12 | 3.42% |
| 2023-03-20 | 2 | $9 | $8 | $8.5 | $11.12 | -23.56% |
| 2023-05-15 | 2 | $8 | $8 | $8 | $11.12 | -28.06% |
| 2023-07-10 | 1 | $8 | $8 | $8 | $11.12 | -28.06% |
| 2023-12-19 | 1 | $12 | $8 | $10 | $11.12 | -10.07% |
| NA | 1 | $NA | $NA | $NA | $11.12 | NA% |
The Trend in the Analyst Price Target
IMNM's average price target has moved down $26 over the prior 34 months.
IMNM reports an average of 29.73% for its upside potential over the past 40 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-17 | 1 | 8 | 8 | 8.0 | 5.69 | 40.6% |
| 2023-03-20 | 2 | 9 | 8 | 8.5 | 5.65 | 50.44% |
| 2023-05-15 | 2 | 8 | 8 | 8.0 | 6.22 | 28.62% |
| 2023-07-10 | 1 | 8 | 8 | 8.0 | 8.20 | -2.44% |
| 2023-12-19 | 1 | 12 | 8 | 10.0 | 8.13 | 23% |
IMNM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 31 months, IMNM's average broker recommendation rating improved by 0.5.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how IMMUNOME INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 28.3% of that group.
- In terms of how IMMUNOME INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -116.91% of that group.
- IMMUNOME INC's upside potential (average analyst target price relative to current price) is higher than 391.72% of stocks in the small market cap category.
- In the context of Healthcare stocks, IMMUNOME INC's average analyst price target is greater than 334.96% of them.
In the Pharmaceutical Products industry, KRON, SPRB, and FHTX are the three stocks most similar to IMMUNOME INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding IMNM using the data that counts. Try POWR Ratings for free.